http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6430063

Outgoing Links

Predicate Object
contentType Clinical Trial|Comparative Study|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 1476
issn 1524-4539
0009-7322
issueIdentifier 12
pageRange 1470-1476
publicationName Circulation
startingPage 1470
bibliographicCitation Batchelor WB, Tolleson TR, Huang Y, Larsen RL, Mantell RM, Dillard P, Davidian M, Zhang D, Cantor WJ, Sketch MH, Ohman EM, Zidar JP, Gretler D, DiBattiste PM, Tcheng JE, Califf RM, Harrington RA. Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and Eptifibatide. Circulation. 2002 Sep 17;106(12):1470–6. doi: 10.1161/01.cir.0000029744.01096.1f. PMID: 12234950.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e127db7f01eba7877476d36f64916c5a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0892b154bc4e1c9eb4172fac09b927cb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc917d32a4b40228b4769d3c990b87f2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_985f0e667f3d98e1dfc59cd3444faa1a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20f9fad47caaf49329f27e2e1249ce84
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e2e70c334e40e5e0f74863bc8824aae1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e123976583717a430aa0d44197bb89ba
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7ad2c796fbb918849737bc44219dff2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5fc1afe8b11a6ac19d1e8da3c55f30cf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9c7942d706737cd691734771065f2330
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65f8b32a23cefbf3f036cf6238016390
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff4ddeb21bb3876f99b957369c1fe69e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_256c891d8304d539d669510b8cd8fd3b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_928455c637739e9138d2077757a1e857
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9065acf6142f6799d5e9e9aa9fe31416
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d8124435abbb5fb6168ec7817f5c3abb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bea6a08d5baeb17ea9e9886845befa8b
date 2002-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/12234950
https://doi.org/10.1161/01.cir.0000029744.01096.1f
isPartOf https://portal.issn.org/resource/ISSN/0009-7322
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2979
https://portal.issn.org/resource/ISSN/1524-4539
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and Eptifibatide
discusses http://id.nlm.nih.gov/mesh/M0017012
http://id.nlm.nih.gov/mesh/M0028793
http://id.nlm.nih.gov/mesh/M0028424
http://id.nlm.nih.gov/mesh/M0011126
http://id.nlm.nih.gov/mesh/M0001357
http://id.nlm.nih.gov/mesh/M0229697
http://id.nlm.nih.gov/mesh/M0001380
http://id.nlm.nih.gov/mesh/M0227707
http://id.nlm.nih.gov/mesh/M0120103
http://id.nlm.nih.gov/mesh/M0016238
http://id.nlm.nih.gov/mesh/M0000915
http://id.nlm.nih.gov/mesh/M0022203
http://id.nlm.nih.gov/mesh/M0211213
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8198
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7065
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_77f2a7aa26c2bfc427c7b9e127e4fda9
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11015
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID133189
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7334
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID448812
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6022
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64781

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128423931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135993536
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136324492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127654660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129747297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129740296
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459

Total number of triples: 70.